Evidence map›Paper›PMID 39725969›Full record

ArticleJournal of nanobiotechnology2024

Unveiling the molecular blueprint of SKP-SCs-mediated tissue engineering-enhanced neuroregeneration.

Hui Zhu, Ying Wang, Siyuan Xu, Yunjian Song, Yifan Li, Yiting Wang, Qiuwen Sun, Muyuan Tong, Tianyi Huang, Yulin Pan and 3 more

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Engineering Silk Fibroin-Based Biomaterials for Neural Repair.Advanced materials (Deerfield Beach, Fla.) · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hui Zhu *Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-innovation Center of Neuroregeneration, NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Nantong University, Nantong, JS, 226001, P. R. China.
Ying Wang *Medical School of Nantong University, Nantong, JS, 226001, P.R. China.
Siyuan Xu *Medical School of Nantong University, Nantong, JS, 226001, P.R. China.
Yunjian SongMedical School of Nantong University, Nantong, JS, 226001, P.R. China.
Yifan LiMedical School of Nantong University, Nantong, JS, 226001, P.R. China.
Yiting WangMedical School of Nantong University, Nantong, JS, 226001, P.R. China.
Qiuwen SunMedical School of Nantong University, Nantong, JS, 226001, P.R. China.
Muyuan TongMedical School of Nantong University, Nantong, JS, 226001, P.R. China.
Tianyi HuangMedical School of Nantong University, Nantong, JS, 226001, P.R. China.
Yulin PanMedical School of Nantong University, Nantong, JS, 226001, P.R. China.
Hongkui WangResearch Center of Clinical Medicine, Affiliated Hospital of Nantong University, Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-innovation Center of Neuroregeneration, NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Nantong University, Nantong, JS, 226001, P. R. China. wanghongkui@ntu.edu.cn.
Xi XuResearch Center of Clinical Medicine, Affiliated Hospital of Nantong University, Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-innovation Center of Neuroregeneration, NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Nantong University, Nantong, JS, 226001, P. R. China. xuxijessica@163.com.
Chengbin XueResearch Center of Clinical Medicine, Affiliated Hospital of Nantong University, Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-innovation Center of Neuroregeneration, NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Nantong University, Nantong, JS, 226001, P. R. China. xue_chengbin@hotmail.com.

Funding

Jiangsu Provincial Key Medical Center, Jiangsu Provincial Medical Innovation Center CXZX202212Jiangsu Provincial Medical Key Discipline ZDXK202240Jiangsu Provincial Research Hospital YJXYY202204, YJXYY202204-ZD04National Key R&D Program of China 2022YFC2409800, 2022YFC2409802National Natural Science Foundation of China Grant No. 82172104Natural Science Foundation of Jiangsu Province BK 20241835
6 · The paper itself

Abstract

Peripheral nerve injury poses a significant challenge to the nervous system's regenerative capacity. We previously described a novel approach to construct a chitosan/silk fibroin nerve graft with skin-derived precursor-induced Schwann cells (SKP-SCs). This graft has been shown to promote sciatic nerve regeneration and functional restoration to a level comparable to that achieved by autologous nerve grafts, as evidenced by behavioral, histological, and electrophysiological assessments. However, the underlying molecular mechanisms based on SKP-SCs mediated tissue engineering-aid regeneration remain elusive. In the present work, we systematically identified gene modules associated with the differentiation of SKPs into SCs by employing weighted gene co-expression network analysis (WGCNA). By integrating transcriptomic data from the regenerated nerve segment, we constructed a network that delineated the molecular signatures of TENG aid neuroregeneration. Subsequent quantitative PCR (qPCR) validation was performed to substantiate the WGCNA findings. Our WGCNA approach revealed a robust molecular landscape, highlighting hub genes pivotal for tissue engineering-aid regeneration. Notably, the upregulation of specific genes was observed to coincide with the acquisition of SC characteristics. The qPCR validation confirmed the expression patterns of these genes, underscoring their role in promoting neuroregeneration. The current study harnesses the power of WGCNA to elucidate the molecular blueprint governing tissue engineering-aid regeneration. The identified gene modules and validated targets offer novel insights into the cellular and molecular underpinnings of tissue engineering-augmented neuroregeneration. These findings pave the way for developing targeted therapeutics and advanced tissue engineering grafts to enhance peripheral nerve repair.

Indexed as

FibroinsNerve RegenerationSchwann CellsSciatic NerveTissue EngineeringAnimalsCell DifferentiationChitosanGene Regulatory NetworksMalePeripheral Nerve InjuriesRatsRats, Sprague-DawleySkinTranscriptomeChitosanFibroinsPeripheral nerve regenerationSchwann cellsSciatic nerve injurySkin-derived precursorsTissue engineeringWeighted gene co-expression network analysis (WGCNA)

Identifiers

PMID39725969
PMCPMC11670488

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.